Drug Most Active Stocks: GW Pharmaceuticals (NASDAQ:GWPH), Merck & Co., Inc. (NYSE:MRK), Bristol-Myers Squibb Co (NYSE:BMY), AstraZeneca (NYSE:AZN)


Shares of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), which develops cannabis-based drugs, are climbing after Morgan Stanley initiated coverage of the stock with an Overweight rating and $103 price target in a note to investors earlier today. WHAT’S NEW: A small but growing set of data suggests that GW’s epilepsy treatments can help patients with refractory epilepsy, the firm wrote. Additionally, U.S. sales of GW’s Sativex, a treatment for MS spasticity and cancer pain, should grow over time, the firm predicted. Shares of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH)closed at $60.86 in last trading session. Yesterday share price of the company was traded in the range of $50.00 – $65.97. Company now has a market value of $900.33 billion. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH)price to sales ratio in past twelve months was calculated as21.50 and price to cash ratio as 18.30.

Merck & Co., Inc. (NYSE:MRK), known as MSD outside the United States and Canada, today announced it is teaming up with Emmy and Golden Globe-winning actress S. Epatha Merkerson on America’s Diabetes Challenge: Get to Your Goals, an educational program intended to encourage people with type 2 diabetes to achieve better control of their blood sugar — a key goal to help reduce the risk of serious health problems. Merkerson, who lives with type 2 diabetes, will travel the country urging people to know their A1C (average blood sugar level over the past two to three months) and to work with their doctors to set and attain their own A1C goal. Merck & Co., Inc. (NYSE:MRK) stock traded in the range of $57.02 – $58.32 and at the end of the day, it closed at $57.77. Average volume of the company is $11.27M. Merck & Co., Inc. (NYSE:MRK)return on equity ratio is recorded as 12.10% and its return on assets is 5.60%.

Bristol-Myers Squibb Co (NYSE:BMY) and Samsung BioLogics today announced the companies will increase the scope of their existing manufacturing agreement in which Samsung will manufacture commercial drug substances and drug product for several Bristol-Myers Squibb biologic medicines at its Incheon manufacturing site. Financial terms of the agreement are not disclosed. Bristol-Myers Squibb Co (NYSE:BMY) after opening at $50.47, moved up 0.95% to $50.99 on last trading day. Company’s 52 week range is $39.18 – $57.49.

AstraZeneca plc (ADR) (NYSE:AZN) rejected the huge deal of $101 billion that was offered by Pfizer Inc. (NYSE:PFE) as an attempt to takeover the British Drug Company. Pfizer is expected to try again for the proposed takeover and might adopt an aggressive approach to attain its objectives. The U.S. pharmaceuticals company is keen to set its cancer franchise. If Pfizer cracks the deal with AstraZeneca, it can get the rights over the immunotherapy. It is an experimental medicine that can have a positive impact on the body’s immune system. It can fight tumors.

AstraZeneca plc (ADR) (NYSE:AZN)stock hit highest price at $68.33, beginning with a price of $67.80 and decreased -3.24% to the close at $66.86 with day range of $66.55 – $68.33. The total market capitalization of the stock is $84.33 billion.


Leave a Reply

Your email address will not be published. Required fields are marked *